FDA Approves St. Jude’s Quadripolar CRT-D Device Following Delay
This article was originally published in The Gray Sheet
Executive Summary
The approval is significant as it marks the entry of the first quadripolar pacing system into the U.S. market. But St. Jude may not get as big of a positive gain from the product as previously expected, analysts suggest.